Delivery Order SPE2DB25D3003-SPE2DB25FPWPK

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Insulin Aspart 100 Unit/mL in 10 mL vials. The contract has a ceiling value of $1,097.40 and an ultimate completion date of May 30, 2025. This order is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL, a critical diabetes medication. The contract has a total ceiling value of $1,098.84 and an ultimate completion date of December 21, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,743,151 units of Insulin Aspart 100 Unit/mL in 10 mL vials, with a ceiling value of $4,266.02. The contract has a firm fixed price pricing type and an ultimate completion date of May 30, 2024. The contract is not designated as a set-aside....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL in 10 mL vials, with a ceiling value of $2,189.41 and a period of performance ending on May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 10 milliliter vials of insulin aspart 100 unit/milliliter. The contract has a firm fixed price of $2,276.20 and an ultimate completion date of May 23, 2025. The award is not set-aside and was issued under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL Vial, 10 mL. The contract has a ceiling value of $1,175.27 and a period of performance through November 13, 2023. The contract is a firm fixed-price delivery order type, with no set-aside requirements indicated. AmerisourceBergen Drug Corp is the prime contractor for this award, which is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Aspart 100 Unit/ML Pen 3ML. The contract is a firm fixed price delivery order with a ceiling value of $6,144.50 and a period of performance through August 20, 2024. The award is not associated with a set-aside designation, indicating open competition. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin aspart 100 unit/mL vials. The contract has a ceiling value of $3,169.20 and a period of performance through June 10, 2025. The contract is not set aside and was awarded on June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML, a medical product used for diabetes management. The contract has a ceiling value of $41,682.05 and a period of performance through November 21, 2023. This contract is a firm fixed price delivery order issued under...
This is a federal delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4564617692 units of Insulin Aspart 100 Unit/mL Vial 10mL. The award is a Firm Fixed Price contract with a ceiling value of $11,209.30 and a performance period ending on May 16, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB25D3003
    Indefinite Delivery Contract
  • SPE2DB25D3003-SPE2DB25FPWPK
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10 milliliter vials of Insulin Aspart 100 Unit/mL, a medication used to treat diabetes. The contract has a ceiling value of $3,127.45 and a completion date of June 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 between AmerisourceBergen and the DLA, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract is not set-aside and is open to competition.

Generated 9/16/25, 9:59 AM